Market Overview

Valeant, Pershing Sweeten Allergan Bid


Valeant Pharmaceuticals said it would hike its cash-and-stock offer to buy Botox-maker Allergan -- a move that's backed by Pershing Square's Bill Ackman.

Partner content
partner content url:

The preceding article is from one of our external contributors. It does not represent the opinion of Benzinga and has not been edited.

Posted-In: M&A News


Related Articles

View Comments and Join the Discussion!
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Survey: What Do Investors Expect For The Upcoming Week?

Major Economic & Central Bank Events On Horizon